Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension

Rationale: Although amphetamines are recognized as “likely” agents to cause drug- and toxin-associated pulmonary arterial hypertension (PAH), (meth)amphetamine-associated PAH (Meth-APAH) has not been well described. Objectives: To prospectively characterize the clinical presentation, histopathology,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Respir Crit Care Med
Autors principals: Zamanian, Roham T., Hedlin, Haley, Greuenwald, Paul, Wilson, David M., Segal, Joshua I., Jorden, Michelle, Kudelko, Kristina, Liu, Juliana, Hsi, Andrew, Rupp, Allyson, Sweatt, Andrew J., Tuder, Rubin, Berry, Gerald J., Rabinovitch, Marlene, Doyle, Ramona L., de Jesus Perez, Vinicio, Kawut, Steven M.
Format: Artigo
Idioma:Inglês
Publicat: American Thoracic Society 2018
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5855067/
https://ncbi.nlm.nih.gov/pubmed/28934596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201705-0943OC
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars